Is Ocular Therapeuticx, Inc. (OCUL) Stock Positioned for Growth After Positive FDA Feedback on Axpaxli?

We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Ocular Therapeuticx, Inc. (NASDAQ:OCUL) is among the best healthcare stocks.

TheFly reported on June 18 that H.C. Wainwright increased its price target on OCUL to $25 from $21 while maintaining a Buy rating on the stock. The firm’s updated outlook followed the company’s discussion of feedback received during a recent Type C meeting with the FDA at its investor day event. H.C. Wainwright indicated that the regulatory update strengthened confidence in Axpaxli’s commercial potential, leading to higher projections for peak annual revenue and an improved assessment of the therapy’s likelihood of obtaining regulatory approval. The firm also noted expectations for strong physician uptake and broad market penetration following a potential launch.

Is Ormat Technologies, Inc. (ORA) The Best Alternative Energy Stock to Buy Now?

A significant corporate development occurred on June 17, when Ocular Therapeuticx, Inc. (NASDAQ:OCUL) outlined its regulatory strategy for AXPAXLI in wet age-related macular degeneration. The company announced plans to submit a New Drug Application in the fourth quarter of 2026 using efficacy and safety results from the SOL-1 trial alongside interim safety findings from SOL-R. OCUL also revised the SOL-R study design to continue evaluating additional endpoints through Week 96 and further differentiate AXPAXLI from existing treatments. In addition, the company streamlined its non-proliferative diabetic retinopathy development program by concentrating resources on the Phase 3 HELIOS-3 trial.

Ocular Therapeuticx, Inc. (NASDAQ:OCUL) is a biopharmaceutical company developing sustained-release therapies for retinal and eye diseases, using its proprietary hydrogel technology to deliver medication directly to the eye.

While we acknowledge the risk and potential of OCUL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OCUL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1